The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Open accessAbstract
Hepatocellular carcinoma (HCC) is a highly aggressive vascular cancer characterized by diverse etiology, activation of multiple signal transduction pathways, and various gene mutations. Here, we have determined a specific role for astrocyte elevated gene-1 (AEG1) in HCC pathogenesis. Expression of AEG1 was extremely low in human hepatocytes, but its levels were significantly increased in human HCC. Stable overexpression of AEG1 converted nontumorigenic human HCC cells into highly aggressive vascular tumors, and inhibition of AEG1 abrogated tumorigenesis by aggressive HCC cells in a xenograft model of nude mice. In human HCC, AEG1 overexpression was associated with elevated copy numbers. Microarray analysis revealed that AEG1 modulated the expression of genes associated with invasion, metastasis, chemoresistance, angiogenesis, and senescence. AEG1 also was found to activate Wnt/beta-catenin signaling via ERK42/44 activation and upregulated lymphoid-enhancing factor 1/T cell factor 1 (LEF1/TCF1), the ultimate executor of the Wnt pathway, important for HCC progression. Inhibition studies further demonstrated that activation of Wnt signaling played a key role in mediating AEG1 function. AEG1 also activated the NF-kappaB pathway, which may play a role in the chronic inflammatory changes preceding HCC development. These data indicate that AEG1 plays a central role in regulating diverse aspects of HCC pathogenesis. Targeted inhibition of AEG1 might lead to the shutdown of key elemental characteristics of HCC and could lead to an effective therapeutic strategy for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y., Place, R. F., Pookot, D., Majid, S., Igawa, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210572 · Cited by 207
RetractedSorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationJemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Self-citationLlovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Self-citationFunctional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
A new member of the frizzled family from Drosophila functions as a Wingless receptor
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,502
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Abou-Alfa, G. K., Schwartz, L., Ricci, S., Amadori, D., Santoro, A., Figer, A., De Greve, J., Douillard, J.-Y., Lathia, C., Schwartz, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3441 · Cited by 1,195
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Self-citationSatoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
Self-citationDrosophila Tcf and Groucho interact to repress Wingless signalling activity
Cavallo, R. A., Cox, R. T., Moline, M. M., Roose, J., Polevoy, G. A., Clevers, H., Peifer, M., & Bejsovec, A. (1998) · Nature · doi:10.1038/26982 · Cited by 730
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
Wurmbach, E., Chen, Y., Khitrov, G., Zhang, W., Roayaie, S., Schwartz, M., Fiel, I., Thung, S., Mazzaferro, V., Bruix, J., et al. (2007) · Hepatology · doi:10.1002/hep.21622 · Cited by 722
Self-citationFocal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
Self-citationBrechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., & Nakamura, Y. (1998) · PubMed · Cited by 514
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
WNT/β‐catenin signaling in liver health and disease
Thompson, M. D., & Monga, S. P. S. (2007) · Hepatology · doi:10.1002/hep.21651 · Cited by 471
Zhu, A. X., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Muzikansky, A., Horgan, K., Sheehan, S., Hale, K. E., Enzinger, P. C., Bhargava, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9130 · Cited by 388
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
Brown, D. M., & Ruoslahti, E. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00079-0 · Cited by 385
Agarwal, R., D'Souza, T., & Morin, P. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1036 · Cited by 374
LOPEZ, P. M., VILLANUEVA, A., & LLOVET, J. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02932.x · Cited by 344
Self-citationPHENOTYPIC STABILITY OF ADULT RAT HEPATOCYTES IN PRIMARY MONOLAYER CULTURE*
Bissell, D. M., & Guzelian, P. S. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb29518.x · Cited by 342
Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini, M., & Perret, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404761101 · Cited by 328
Su, Z.-Z., Kang, D.-C., Chen, Y., Pekarskaya, O., Chao, W., Volsky, D. J., & Fisher, P. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205445 · Cited by 320
Self-citationCloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1
Kang, D.-C., Su, Z.-Z., Sarkar, D., Emdad, L., Volsky, D. J., & Fisher, P. B. (2005) · Gene · doi:10.1016/j.gene.2005.04.006 · Cited by 287
Self-citationLeung, T. W. T., Patt, Y. Z., Lau, W. Y., Ho, S. K. W., Yu, S. C. H., Chan, A. T. �., Mok, T. S. K., Yeo, W., Liew, C.-T., Leung, N. W. Y., et al. (1999) · PubMed · Cited by 278
Emdad, L., Sarkar, D., Su, Z.-Z., Randolph, A., Boukerche, H., Valerie, K., & Fisher, P. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3029 · Cited by 276
Self-citationKatoh, M., & Katoh, M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.9.3151 · Cited by 253
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
Feitelson, M. A., & Duan, L. (1997) · Europe PMC (PubMed Central) · Cited by 248
Wnt-3A/β-Catenin Signaling Induces Transcription from the LEF-1 Promoter
Filali, M., Cheng, N., Abbott, D., Leontiev, V., & Engelhardt, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107977200 · Cited by 241
Molecular Basis of Nuclear Factor-κB Activation by Astrocyte Elevated Gene-1
Sarkar, D., Park, E. S., Emdad, L., Lee, S.-G., Su, Z.-Z., & Fisher, P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6164 · Cited by 232
Self-citationYe, X., Zerlanko, B., Kennedy, A., Banumathy, G., Zhang, R., & Adams, P. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.034 · Cited by 228
Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029
Gesierich, S., Berezovskiy, I., Ryschich, E., & Zöller, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0391 · Cited by 226
Prognostic molecular markers in hepatocellular carcinoma: A systematic review
Mann, C. D., Neal, C. P., Garcea, G., Manson, M. M., Dennison, A. R., & Berry, D. P. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.004 · Cited by 218
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
Lee, S.-G., Su, Z.-Z., Emdad, L., Sarkar, D., Franke, T. F., & Fisher, P. B. (2008) · Oncogene · doi:10.1038/sj.onc.1210713 · Cited by 217
Self-citationLee, S.-G., Su, Z.-Z., Emdad, L., Sarkar, D., & Fisher, P. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608386103 · Cited by 214
Self-citationIncreased MAPK Expression and Activity in Primary Human Hepatocellular Carcinoma
Schmidt, C. M., McKillop, I. H., Cahill, P. A., & Sitzmann, J. V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6840 · Cited by 212
Townsley, F. M., Cliffe, A., & Bienz, M. (2004) · Nature Cell Biology · doi:10.1038/ncb1141 · Cited by 209
Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
Biology of Hepatocellular Carcinoma
Pang, R. W. C., Joh, J. W., Johnson, P. J., Monden, M., Pawlik, T. M., & Poon, R. T. P. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9730-z · Cited by 174
Emdad, L., Sarkar, D., Su, Z.-Z., Lee, S., Kang, D., Bruce, J. N., Volsky, D. J., & Fisher, P. B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.010 · Cited by 164
Self-citationFang, M., Li, J., Blauwkamp, T., Bhambhani, C., Campbell, N., & Cadigan, K. M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601153 · Cited by 164
Genetics of hepatocellular carcinoma
Teufel, A., Staib, F., Kanzler, S., Weinmann, A., Schulze-Bergkamen, H., & Galle, P. R. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i16.2271 · Cited by 139
Coutant, A., Rescan, C., Gilot, D., Loyer, P., Guguen‐Guillouzo, C., & Baffet, G. (2002) · Hepatology · doi:10.1053/jhep.2002.36160 · Cited by 135
The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals
Hodgson, E., & Rose, R. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.10.002 · Cited by 134
MRP8/ABCC11 directly confers resistance to 5-fluorouracil
Oguri, T., Bessho, Y., Achiwa, H., Ozasa, H., Maeno, K., 前田, 浩., Sato, S., & Ueda, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0529 · Cited by 132
Nair, R. R., Solway, J., & Boyd, D. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602703200 · Cited by 120
Calvisi, D. F., Factor, V. M., Loi, R., & Thorgeirsson, S. S. (2001) · PubMed · Cited by 112
Sutherland, H. G. E., Lam, Y. W., Briers, S., Lamond, A. I., & Bickmore, W. A. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.020 · Cited by 110
p53-dependent transcriptional repression of p21waf1 by hepatitis C virus NS3
Kwun, H. J., Jung, E. Y., Ahn, J. Y., Lee, M. N., & Jang, K. L. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-9-2235 · Cited by 98
McKillop, I. H., Schmidt, C. M., Cahill, P. A., & Sitzmann, J. V. (1997) · Hepatology · doi:10.1002/hep.510260615 · Cited by 81
Powell, C. M. H., Rudge, T. L., Zhu, Q., Johnson, L. F., & Hansen, U. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4665 · Cited by 77
Oguri, T., Achiwa, H., Bessho, Y., Muramatsu, H., 前田, 浩., Niimi, T., Sato, S., & Ueda, R. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.05.003 · Cited by 64
Cited by
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
He, X.-X., Chang, Y., Meng, F.-Y., Wang, M.-Y., Xie, Q.-H., Tang, F., Li, P.-Y., Song, Y.-H., & Lin, J.-S. (2012) · Oncogene · doi:10.1038/onc.2011.500 · Cited by 339
EMT in cervical cancer: Its role in tumour progression and response to therapy
Qureshi, R., Arora, H., & Rizvi, M. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.09.021 · Cited by 301
The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
Hu, G., Wei, Y., & Kang, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0049 · Cited by 266
Metadata
- Authors
- Yoo, B. K., Emdad, L., Su, Z.-Z., Villanueva, A., Chiang, D. Y., Mukhopadhyay, N. D., Mills, A. S., Waxman, S., Fisher, R. A., Llovet, J. M., Fisher, P. B., & Sarkar, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-03-02
- Volume
- 119
- Issue
- 3
- Pages
- 465-477
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2058148459
- Cited by
- 328
- References
- 71
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.